Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,829.73
-1.9733-0.11%
Number of Gainers:8
Number of Losers:10
Number of Flat:1
PE:- -
High:1,847.82
Open:1,834.63
Low:1,827.63
Close:1,831.70
Volume:81.68M
Turnover:6.29B
Market Cap:1.49T
Float Cap:1.45T

Loading ...

Novartis India to Acquire 'Minipress' Trademarks from Pfizer

Reuters
·
Sep 07

AstraZeneca Scores Minor Positive with U.S. Approval for Breast-Cancer Drug

Dow Jones
·
Sep 07

Pfizer Ramps Up Obesity And Eczema Bets, Investors Watch

TIPRANKS
·
Sep 05

Nvidia, TSMC, Salesforce, CrowdStrike, J&J Insider Shake‑Up

TIPRANKS
·
Sep 05

AstraZeneca Gets FDA Approval for Breast Cancer Treatment

Dow Jones
·
Sep 05

Novavax Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 05

Pfizer Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 05

Co-Diagnostics - Brian Brown Steps Down as CFO Effective September 2, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 05

Co-Diagnostics Names Daniel Bohrer Principal Financial Officer, Replacing Brian Brown

Reuters
·
Sep 05

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Dow Jones
·
Sep 05

iBio Announces Annual Shareholder Meeting

Reuters
·
Sep 05

Equillium Price Target Maintained with a $12.00/Share by Roth Capital

Dow Jones
·
Sep 05

Pfizer’s Next Move in Obesity Drugs: What the New VESPER-JM Trial Means for PFE Investors

TIPRANKS
·
Sep 05

Pfizer Steps Up in Obesity Race With New Phase 3 Berobenatide Trial in Japan

TIPRANKS
·
Sep 05

Pfizer’s Tilrekimig Eczema Trial: A Fresh Phase 3 Catalyst for PFE Investors

TIPRANKS
·
Sep 05

Pfizer’s Migraine Tablet Study Wraps Up, Supporting Pipeline Flexibility for PFE Investors

TIPRANKS
·
Sep 05

AstraZeneca PLC Stock Falls Friday, Underperforms Market

Dow Jones
·
Sep 05

Alnylam's Zilebesiran Sees Commercial Opportunity From Baxfendy Launch, Oppenheimer Says

MT Newswires Live
·
Sep 04

J&J EVP, Worldwide Chair MedTech Timothy Schmid Disposes of 33,597 Common Shares Worth $9.23 Million

Reuters
·
Sep 04

Co-Diagnostics - Annual Meeting Adjourned to Sept 24, 2026 at Company Offices - SEC Filing

THOMSON REUTERS
·
Sep 04